Evidence map›Paper›PMID 28399164›Full record

ArticlePloS one2017

Sequential monitoring of lymphocyte subsets and of T-and-B cell neogenesis indexes to identify time-varying immunologic profiles in relation to graft-versus-host disease and relapse after allogeneic stem cell transplantation.

Cristina Skert, Simone Perucca, Marco Chiarini, Viviana Giustini, Alessandra Sottini, Claudia Ghidini, Stefano Martellos, Federica Cattina, Benedetta Rambaldi, Valeria Cancelli and 6 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 1 country.

Cristina SkertChair of Haematology, Stem Cell Transplantation Unit, University of Brescia, Brescia, Italy.
Simone PeruccaCentro Ricerca Emato-oncologica AIL (CREA), Spedali Civili of Brescia, Brescia, Italy.
Marco ChiariniCentro Ricerca Emato-oncologica AIL (CREA), Spedali Civili of Brescia, Brescia, Italy.
Viviana GiustiniCentro Ricerca Emato-oncologica AIL (CREA), Spedali Civili of Brescia, Brescia, Italy.
Alessandra SottiniCentro Ricerca Emato-oncologica AIL (CREA), Spedali Civili of Brescia, Brescia, Italy.
Claudia GhidiniCentro Ricerca Emato-oncologica AIL (CREA), Spedali Civili of Brescia, Brescia, Italy.
Stefano MartellosDepartment of Life Sciences, Research Unit of Biodiversity Informatics, University of Trieste, Trieste, Italy.
Federica CattinaChair of Haematology, Stem Cell Transplantation Unit, University of Brescia, Brescia, Italy.
Benedetta RambaldiChair of Haematology, Stem Cell Transplantation Unit, University of Brescia, Brescia, Italy.
Valeria CancelliChair of Haematology, Stem Cell Transplantation Unit, University of Brescia, Brescia, Italy.
Michele MalagolaChair of Haematology, Stem Cell Transplantation Unit, University of Brescia, Brescia, Italy.
Alessandro TurraChair of Haematology, Stem Cell Transplantation Unit, University of Brescia, Brescia, Italy.
Nicola PolverelliChair of Haematology, Stem Cell Transplantation Unit, University of Brescia, Brescia, Italy.
Simona BernardiCentro Ricerca Emato-oncologica AIL (CREA), Spedali Civili of Brescia, Brescia, Italy.
Luisa ImbertiCentro Ricerca Emato-oncologica AIL (CREA), Spedali Civili of Brescia, Brescia, Italy.
Domenico RussoChair of Haematology, Stem Cell Transplantation Unit, University of Brescia, Brescia, Italy.
University of Brescia · ITAzienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia · ITUniversity of Trieste · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

T and B lymphocyte subsets have been not univocally associated to Graft-versus-host disease (GVHD) and relapse of hematological malignancies after stem cell transplantation (SCT). Their sequential assessment together with B and T cell neogenesis indexes has been not thoroughly analysed in relation to these changing and interrelated immunologic/clinic events yet. Lymphocyte subsets in peripheral blood (PB) and B and T cell neogenesis indexes were analysed together at different time points in a prospective study of 50 patients. Principal component analysis (PCA) was used as first step of multivariate analysis to address issues related to a high number of variables versus a relatively low number of patients. Multivariate analysis was completed by Fine-Gray proportional hazard regression model. PCA identified 3 clusters of variables (PC1-3), which correlated with acute GVHD: PC1 (pre-SCT: KRECs≥6608/ml, unswitched memory B <2.4%, CD4+TCM cells <45%; HR 0.5, p = 0.001); PC2 (at aGVHD onset: CD4+>44%, CD8+TCM cells>4%; HR 1.9, p = 0.01), and PC3 (at aGVHD onset: CD4+TEMRA<1, total Treg<4, TregEM <2 cells/μl; HR 0.5, p = 0.002). Chronic GVHD was associated with one PC (TregEM <2 cells/μl at day+28, CD8+TEMRA<43% at day+90, immature B cells<6 cells/μl and KRECs<11710/ml at day+180; HR 0.4, P = 0.001). Two PC correlated with relapse: PC1 (pre-SCT: CD4+ <269, CD4+TCM <120, total Treg <18, TregCM <8 cells/μl; HR 4.0, p = 0.02); PC2 (pre-SCT mature CD19+ >69%, switched memory CD19+ = 0 cells and KRECs<6614/ml at +90; HR 0.1, p = 0.008). All these immunologic parameters were independent indicators of chronic GVHD and relapse, also considering the possible effect of previous steroid-therapy for acute GVHD. Specific time-varying immunologic profiles were associated to GVHD and relapse. Pre-SCT host immune-microenvironment and changes of B cell homeostasis could influence GVH- and Graft-versus-Tumor reactions. The paradoxical increase of EM Treg in PB of patients with GVHD could be explained by their compartmentalization outside lymphoid tissues, which are of critical relevance for regulation of GVH reactions.

Indexed as

Hematopoietic Stem Cell TransplantationLymphocyte SubsetsAdolescentAdultAgedB-LymphocytesFemaleFlow CytometryGraft vs Host DiseaseHumansMaleMiddle AgedRecurrenceT-LymphocytesTransplantation, HomologousYoung Adult

Identifiers

PMID28399164
PMCPMC5388479
OpenAlexW2606473042

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.